Чтение онлайн

12.Laurell CB, Erickson S. The electrophoretic a1-globulin pattern of serum in a1-antitrypsin deficiency.// Scan J Clin Lab Invest 1963;15:132 - 140

13.Gross P, Babjak M, Tolker E, et al. Enzymatically produced pulmonary emphysema: A preliminary report.//J Occup Med 1964; 6:481-484

14.Mercer R., Crapo J. D. Structural changes in elastic fibers after pancreatic elastase administration in hamsters. //J. Appl. Physiol. 1992; 72: 1473-1479

15.Orsos F.: Au Uber das elastische Gerauust der normalen und der emphysematosen Lunge.// Pathol. Anat. 41: 95-121, 1907.

16.Hogg JC, Senior RM Chronic obstructive pulmonary disease: Pathology and biochemistry of emphysema// Thorax 2002;57:830-834

17.American Thoracic Society. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency.// Am. J. Respir. Crit Care Med. 2003;168: 818-900

18.The Alpha 1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha 1-antitrypsin. Am. J. Respir Criti Care Med. 1998; 158:49-59

19. Carp H., Miller F., Hoidal J.R., Janoff A. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity.// Proc. Natl. Acad. Sci. USA. 1982 ; 79: 2041 - 2045.

20.Taggart C., Cervantes-Laurean D., Kim G. Oxidation of either Methionine 351 or Methionine 358 in 1-Antitrypsin Causes Loss of Anti-neutrophil Elastase Activity. J. Biol. Chem. 2000; 275 (35) : 27258-27265.

21.Finlay, GA, O’Driscoll, LR, Russell, KJ, et al: Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.// Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 240-247

22.Vernooy J, Lindeman J H, Jacobs JA: Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD// Chest. 2004;126:1802-1810

23.Imai K, Dalal S, Chen E Human Collagenase (Matrix Metalloproteinase-1) Expression in the Lungs of Patients with Emphysema// Am. J. Respir. Crit. Care Med., Volume 163, Number 3, March 2001, 786-791

24.Selman M, Cisneros-Lira J, Gaxiola M et al: Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs// Chest (2003) 123: 1633-1641.

25.Beeh KM, Beier J, Kornmann O, Buhl R Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1 and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.// Respir Med 97(2003): 634-639

26.Higashimoto Y, Yamagata Y Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients// Eur Respir J. 2005 May;25(5):885-90.

27. Vignola A, Riccobono M, Mirabella A. Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis //Am. J. Respir. Crit. Care Med., Volume 158, Number 6, December 1998, 1945-1950

28.Joyce E. Rundhaug Matrix metalloproteinases and angiogenesis// J. Cell. Mol. Med. Vol 9, No 2, 2005 pp. 267-285

29.Russell RE, Thorley A, Culpitt SV et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases// Am J Physiol Lung Cell Mol Physiol 2002;283:867 - 873.

30. Takeyabu K, Betsuyaku T, Nishimura M et al. Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema// Eur Respir J 1998;12:1033 - 1039

31.Wang Z, Zheng T, Zhu Z et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung// J Exp Med 2000;192:1587 - 1600

32.Henson P.M., Vandivier RW, Douglas S.I. Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?// The Proceedings of the American Thoracic Society (2006)3:713-717

33.Fang KC, Wolters PJ, Steinhoff M, et al. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.// J Immunol 1999;162:5528 - 35

34.Kucich U, Rosenbloom JC, Abrams WR, et al.: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta and p38.// Am J Respir Cell Mol Biol 2002;26:183 - 8

35.Bonniaud P, Kolb M, Galt T et al: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.//J Immunol 2004;173:2099 - 2108

36.Pons R, Sauleda J., Noguera A. et al: Decreased macrophage release of TGF-бета and TIMP-1 in chronic obstructive pulmonary disease // Eur. Respir. J., July 1, 2005; 26(1): 60 - 66

37.Aoshiba K, Nagai A. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.//Clin Rev Allergy Immunol 2004;27:35 - 43

38.Hodge S, Hodge G, Scicchitano R et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.// Immunol Cell Biol. 2003;81:289 - 296.

39.Vandivier RW, Fadok VA, Hoffmann PR et al: Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.// J Clin Invest. 2002;109:661 - 670

40.Vlanovich G, Russel ML, Mercer RR, Crapo JD . Cellular and Connective Tissue Changes in Alveolar Septal Walls in Emphysema //Am. J. Respir. Crit. Care Med., Vol 160, Number 6, 1999, 2086-2092

41.Massaro GD, Radaeva S, Clerch LB, Massaro D. Lung alveoli: endogenous programmed destruction and regeneration// Am J Physiol Lung Cell Mol Physiol 2002.283: 305-309

42.Barnes P. J., Stockley R. A. COPD: current therapeutic interventions and future approaches //Eur Respir J 2005; 25:1084-1106

43.Stein J, Fenigstein H. Pathological anatomy of hunger disease.// In: Winick M, editor. Hunger disease: studies by the Jewish physicians in the Warsaw Ghetto: current concepts in nutrition. New York: John Wiley & Sons; 1979. p. 207 - 211

44.Kerr JS, Riley DJ, Lanza-Jacoby S, et al. Nutritional emphysema in the rat // Am Rev Respir Dis 1985;131:644 - 650